CCGB(SZ:300138) Zheng Quan Ri Bao·2025-10-13 14:12Group 1 - The core viewpoint of the article is that Chenguang Biological has announced a significant increase in its expected net profit for the first three quarters of 2025, projecting a range of 278 million to 314 million yuan, which represents a growth of 344.05% to 401.55% compared to the same period last year [2] Group 2 - The company anticipates that the net profit attributable to shareholders will be between 278 million yuan and 314 million yuan for the first three quarters of 2025 [2] - The projected growth rate indicates a substantial improvement in the company's financial performance compared to the previous year [2] - This announcement reflects the company's positive outlook and potential for strong earnings growth in the upcoming quarters [2]